Opiods Inc.

Pushing opioids, bribing doctors and making millions.

Frontline and the Financial Times investigate how Insys Therapeutics profited from a fentanyl-based painkiller up to 100 times stronger than heroin — and how some Wall Street investors looked the other way.

This journalism is made possible by viewers like you. Support your local PBS station here: http://www.pbs.org/donate